Gamehost cancels deal with Oncothyreon – BusinessWeek

By admin

Gamehost cancels deal with Oncothyreon
BusinessWeek
Biotechnology drug developer Oncothyreon Inc. said a deal announced last month to sell its interest in Oncothyreon Canada Inc. for about $8.2 million has
Oncothyreon announces termination of arrangement agreementPR Newswire (press release)

all 34 news articles »



categoriaBiotechnology commentoNo Comments | dataMarch 9th, 2010

About... admin

This author published 9263 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

You must be logged in to send a comment.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Web Design by PlatinumShore.com & Web Hosting by TradeWebHosting.com